Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PLACEBO for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where PLACEBO was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for PLACEBO

Side Effect Reports % Deaths Hosp.
Nausea 18 5.8% 0 16
Blood prolactin abnormal 15 4.8% 4 6
Sexual dysfunction 15 4.8% 4 6
Pneumonia 14 4.5% 4 10
Sedation 13 4.2% 4 6
Dyskinesia 12 3.9% 4 6
Dystonia 12 3.9% 4 6
Vomiting 12 3.9% 0 11
Cardiac failure 11 3.5% 3 8
Dizziness 11 3.5% 0 10
Anaemia 10 3.2% 0 10
Drug ineffective 10 3.2% 4 1
Headache 10 3.2% 0 8
Insurance issue 10 3.2% 2 6
Akathisia 9 2.9% 0 6

Other Indications for PLACEBO

Product used for unknown indication (16) Malignant melanoma (15) Rheumatoid arthritis (12) Breast cancer (11) Ovarian cancer (11) Type 2 diabetes mellitus (11) Hiv infection (10) Cardiovascular disorder (9) Her2 positive breast cancer (9) Non-small cell lung cancer metastatic (9)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

PLACEBO Full Profile All Diffuse large b-cell lymphoma Drugs PLACEBO Demographics PLACEBO Timeline